TY - JOUR T1 - Aldosterone receptor antagonists for heart failure: Current status, future indications JF - Cleveland Clinic Journal of Medicine JO - Cleve Clin J Med SP - 257 LP - 268 VL - 73 IS - 3 AU - Bertram Pitt AU - Sanjay Rajagopalan Y1 - 2006/03/01 UR - http://www.ccjm.org/content/73/3/257.abstract N2 - Many patients with heart failure should receive an aldosterone receptor antagonist, ie, either spironolactone (Aldactone) or the newer agent eplerenone (Inspra)—in addition to an angiotensin-converting enzyme (ACE) inhibitor or an angiotensin II receptor blocker (ARB) or both, and a beta-blocker. We review the evidence and indications. ER -